United States · FDA National Drug Code directory
Anagrelide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62135-312_13156e50-28d1-0994-e063-6394a90a16ec
- Product NDC
- 62135-312
- Form
- CAPSULE
- Composition / generic term
- Anagrelide
- Labeler
- Chartwell RX, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20050418
- Source listing expiry
- 20261231
Source-listed ingredients
- ANAGRELIDE HYDROCHLORIDE ANHYDROUS — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 CAPSULE in 1 BOTTLE (62135-312-12) · 62135-312-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →